SCHEMBL1178

SCHEMBL1178

[C]1=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4175824 0.67
SCHEMBL958835 0.57
SCHEMBL31324312 0.38
SCHEMBL29889134 0.38
Charcoal, Activated SCHEMBL2400332 0.38
SCHEMBL6559802 0.38
Methane SCHEMBL23853849 0.38
SCHEMBL74539 0.27
Bromide SCHEMBL9351108 0.27
Water SCHEMBL490048 0.27

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 37551 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238264-A1 INHIBITORS OF SARM1 NADASE ACTIVITY AND USES THEREOF DISARM THERAPEUTICS, INC. 2024-07-18 US claimed
US-20240238432-A1 METHOD FOR GLYCOPROTEIN MODIFICATION HONEYBEAR BIOSCIENCES INC. (TW) 2024-07-18 US claimed
CN-114206884-B Thienopyrimidine derivatives as ACC inhibitors and use thereof 吉利德科学公司 2024-07-12 CN claimed
WO-2024145600-A1 METHOD FOR GLYCOPROTEIN MODIFICATION HONEYBEAR BIOSCIENCES INC. (TW) 2024-07-04 WO claimed
EP-4387607-A1 NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS Tiba Biotech LLC (US) 2024-06-26 EP claimed
CN-118221763-A Compounds and conjugates thereof 免疫医疗有限公司 2024-06-21 CN claimed
US-12012390-B2 Flavone compounds for the treatment and prophylaxis of hepatitis B virus disease HOFFMANN-LA ROCHE INC. (US) 2024-06-18 US claimed
US-20240174996-A1 METHOD FOR SITE-SPECIFIC CONJUGATION OF NUCLEIC ACID TO CRISPR FAMILY PROTEIN, AND CONJUGATE THEREOF AND USE THEREOF BEIJING HUIDA BIOTECHNOLOGY CO., LTD (CN) 2024-05-30 US claimed
CN-117157299-B Tricyclic heterocyclic derivative, composition and application thereof 北京丹擎医药科技有限公司 2024-05-28 CN claimed
US-20240140954-A1 TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO., LTD. (CN) 2024-05-02 US claimed
EP-0792252-A1 MONOMERS AND COMPOSITION WHICH CAN BE CROSSLINKED AND CROSSLINKED POLYMERS Ciba SC Holding AG (CH) 1997-09-03 EP claimed
EP-0772606-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE &amp; CO. (US) 1997-05-14 EP claimed
EP-0760208-A2 Compositions having synergistic fungitoxic effects ROHM AND HAAS COMPANY (US) 1997-03-05 EP claimed
WO-1996024629-A1 POLYMERISABLE COMPOSITION, PROCESS FOR PRODUCING CROSS-LINKED POLYMERS, AND CROSS-LINKABLE POLYMERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1996-08-15 WO claimed
WO-1996016008-A1 MONOMERS AND COMPOSITION WHICH CAN BE CROSSLINKED AND CROSSLINKED POLYMERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1996-05-30 WO claimed
WO-1996003392-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO claimed
EP-0598095-A1 MEDIATORS TO OXIDOREDUCTASE ENZYMES MediSense, Inc. (US) 1994-05-25 EP claimed
WO-1993025898-A1 MEDIATORS TO OXIDOREDUCTASE ENZYMES MEDISENSE, INC. (US) 1993-12-23 WO claimed
US-4960766-A SUBSTITUTED 2-PYRAZOLIOMETHYL GROUP AND A 7-(AMINOTHIAZOLYL) (ALKOXYIMINO)-ACETAMIDO GROUP CEPHALOSPORIN DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-10-02 US claimed
EP-0118801-A2 A catalyst for isomerization reaction SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-09-19 EP claimed